Dose adjusted‐EPOCH‐R and mediastinal disease may improve outcomes for patients with gray‐zone lymphoma
Sign Up to like & getrecommendations! Published in 2017 at "British Journal of Haematology"
DOI: 10.1111/bjh.14226
Abstract: in 7 5% of cells, del(13q) in 45% of cells and was negative for t(11;14). The patient received a single dose of bendamustine and rituximab, however B-cell lymphocytosis persisted. Upon completion of the 28-d cycle,… read more here.
Keywords: epoch mediastinal; dose adjusted; mediastinal disease; disease ... See more keywords